Works by Chan, Kylie Sze‐Wing

Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study.

Published in:

Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 574, doi. 10.1111/dom.16049

By:

• Lee, Chi‐Ho;
• Lui, David Tak‐Wai;
• Mak, Lung‐Yi;
• Fong, Carol Ho‐Yi;
• Chan, Kylie Sze‐Wing;
• Mak, Jimmy Ho‐Cheung;
• Cheung, Chloe Yu‐Yan;
• Chow, Wing‐Sun;
• Woo, Yu‐Cho;
• Yuen, Man‐Fung;
• Seto, Wai‐Kay;
• Lam, Karen Siu‐Ling

Publication type:

Article